Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)


Phase 2 Results

Summary of Purpose

The purpose of this study is to assess the safety and tolerability of AZD0837 in patients with atrial fibrillation who are unable or unwilling to take vitamin K antagonist therapy for up to 3 months.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 March 2012.

1 Oct 2007 15 Feb 2008 1 Oct 2008 1 Oct 2008 1 Mar 2012 30 Jun 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment


Not available